Children's Hospital of Philadelphia (CHOP) is the first hospital in the United States devoted exclusively to the care of children. Since its start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic “firsts” in pediatric medicine. Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives, worldwide.
Our physicians are internationally-recognized experts in every pediatric specialty, including cancer, cardiac care, fetal medicine, orthopaedics, neonatology, endocrinology, gastroenterology and urology. Children’s Hospital is also consistently recognized as a national leader in the advancement of healthcare for children: for the 17th straight year, U.S. News & World Report ranked CHOP among the best children’s hospitals in the United States, and awarded it the elite recognition of No. 4, on its 2023-24 Honor Roll.
U.S. News also ranked the Department of Pediatrics at the University of Pennsylvania’s Perelman School of Medicine, located at CHOP, as the No. 1 Department of Pediatrics in the country by U.S. News for the last 11 years.
A critical part of CHOP’s mission to be the leader in advancing healthcare for children globally is the ability to robustly integrate novel research into the high-quality clinical care it delivers. Celebrating its 100th anniversary in 2022, Children's Hospital of Philadelphia Research Institute is one of the largest pediatric research programs in the United States with nearly $350 million in total grant funding, and over 1000 principal investigators (with active grants/protocols).
Medtech Corporation represents World’s Best technology partners in Genomics & Life Science, Routine Clinical Laboratory Sciences, Medical, Surgical, Dental and Pharmaceutical Companies in Qatar and the region. Supported by Expert Scientists and Engineers, we provide Superior Tools and Knowledge for advancing Healthcare and Reseach outcomes
CosmosID offers end-to-end microbiome science solutions from discovery through clinical validation: short- and long-read DNA sequencing, metabolomics, RNA sequencing, multi-omics analysis and systems biology expertise. Pipelines are supported by CLIA-certified & ICH-GCP compliant NGS, metabolomic, and advanced bioinformatics solutions. CosmosID also offers a user-friendly cloud software for microbiome comparative analysis and statistics.
New Concept Pharma, we are much more than just a distributor - we are your comprehensive partner for all your needs in healthcare, research, veterinary care, diagnostics, life sciences, laboratory sciences, food safety, technical support, applications, and training. With a relentless commitment to excellence, we have earned the trust and credibility of both the healthcare industry and our valued customers. Our unwavering presence in the healthcare landscape has solidified our position as a powerful partner for some of the world's leading healthcare brands. Like Oxford Nanopore Technologies, Euroimmun, Omixon, Better You, Elga, etc.
We are driven by the desire for long-term growth and value for our customers, constantly transforming innovation into practical solutions. We take immense pride in our role as a conduit between the world's foremost medical manufacturers and discerning customers. Our distribution model is designed for your convenience, offering unwavering support, timely delivery of top-quality equipment, and periodic servicing. Our team of highly qualified engineers collaborates closely with each manufacturer's technical support team, guaranteeing round-the-clock excellence in service.
Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has 62 NGS-related patents, as well as nearly 20,000 SCI articles with a total impact factor of nearly 120,000, including publications in first tiers journals such as Cell, Nature and Science. As the largest NGS service provider headquartered in Beijing with branches in Hong Kong China, US, UK, Singapore, Netherlands, and Japan, Novogene was founded in 2011 and has been growing rapidly over the past few years.
